Crossmark

Safety and efficacy outcomes at 1 year after MitraClip therapy for percutaneous mitral valve repair in patients with severe mitral regurgitation: the Egyptian experience

Crossref DOI link: https://doi.org/10.1186/s43044-021-00166-5

Published Online: 2021-05-03

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elbelbesy, Radwa Abdullah https://orcid.org/0000-0003-0239-1271
Elsawah, Ahmed Mohsen https://orcid.org/0000-0003-3825-9555
Ammar, Ahmed Shafie https://orcid.org/0000-0002-2882-7283
Khamis, Hazem Abdelmohsen https://orcid.org/0000-0003-3832-8063
Shehata, Islam Elsayed https://orcid.org/0000-0002-3850-9027
License Information

Text and Data Mining valid from 2021-05-03

Version of Record valid from 2021-05-03
More Information

Article History

Received: 11 January 2021

Accepted: 22 April 2021

First Online: 3 May 2021

Declarations

:

: The protocol was approved by Zagazig University Institutional Review Board (ZU-IRB#2481-17-2-2016) which confirmed that all methods were performed in accordance with the Declaration of Helsinki. Informed written consent was obtained from all participants.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below